Compounds > dan 2163

dan 2163 and naloxone

dan 2163 has been researched along with naloxone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bellman, K; Knegtel, RM; Settimo, L1
Backer, MM; Bloch, M; Pick, CG; Rigai, T; Schreiber, S; Weizman, T1
Cordonnier, L; Noble, F; Roques, BP; Sanchez, M1
Chand, P; Rehni, AK; Singh, TG1

Other Studies

6 other study(ies) available for dan 2163 and naloxone

ArticleYear
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms.
    European journal of pharmacology, 2003, Oct-08, Volume: 478, Issue:2-3

    Topics: Amisulpride; Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Naloxone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid; Sulpiride

2003
Facilitation of enkephalins-induced delta-opioid behavioral responses by chronic amisulpride treatment.
    Neuroscience, 2005, Volume: 135, Issue:1

    Topics: Amisulpride; Animals; Behavior, Animal; Disulfides; Dopamine Antagonists; Enkephalins; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Pain Measurement; Phenylalanine; Reaction Time; Receptors, Opioid, delta; Sulpiride; Swimming

2005
Amisulpride-induced seizurogenic effect: a potential role of opioid receptor-linked transduction systems.
    Basic & clinical pharmacology & toxicology, 2011, Volume: 108, Issue:5

    Topics: Amines; Amisulpride; Analysis of Variance; Animals; Anti-Asthmatic Agents; Cromolyn Sodium; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbred Strains; Naloxone; Receptors, GABA; Receptors, Histamine H1; Receptors, Opioid; Seizures; Sulpiride

2011